Robotic Assisted Laparoscopic Radical Prostatectomy: A Review of the Current State of Affairs

V. R. Patel; M. F. Chammas Jr; S. Shah


Int J Clin Pract. 2007;61(2):309-314. 

In This Article

Summary and Introduction


Open retropubic radical prostatectomy is the gold standard treatment for localised prostate cancer. However, the procedure has inherent morbidity associated to it. Therefore, less invasive surgical techniques have been sought, one such alternative is robotic-assisted laparoscopic radical prostatectomy. The advantages provided by robotic technology have the potential to minimise patient morbidity while improving both functional and oncological outcomes. Although it is a recent technological advancement, robotic surgery has shown an increasing rate of adoption worldwide. Currently more than 30,000 patients have undergone this procedure worldwide. We present a review of the available literature on robotic-assisted laparoscopic radical prostatectomy.


In the USA, approximately 77,000 radical prostatectomies are performed yearly for the treatment of prostate cancer. The gold standard for treatment is open retropubic radical prostatectomy (RRP) which has demonstrated a reduction in disease-specific mortality for patients with localised prostate cancer.[1] However, this treatment option is invasive and can potentially lead to significant morbidity. Therefore, patients and surgeons alike have sought out less invasive surgical options. One alternative is robotically assisted laparoscopic radical prostatectomy (RALP).


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.